chr21-38398442-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_182918.4(ERG):​c.745+2132A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.387 in 152,084 control chromosomes in the GnomAD database, including 12,741 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.39 ( 12741 hom., cov: 32)

Consequence

ERG
NM_182918.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.165

Publications

5 publications found
Variant links:
Genes affected
ERG (HGNC:3446): (ETS transcription factor ERG) This gene encodes a member of the erythroblast transformation-specific (ETS) family of transcriptions factors. All members of this family are key regulators of embryonic development, cell proliferation, differentiation, angiogenesis, inflammation, and apoptosis. The protein encoded by this gene is mainly expressed in the nucleus. It contains an ETS DNA-binding domain and a PNT (pointed) domain which is implicated in the self-association of chimeric oncoproteins. This protein is required for platelet adhesion to the subendothelium, inducing vascular cell remodeling. It also regulates hematopoesis, and the differentiation and maturation of megakaryocytic cells. This gene is involved in chromosomal translocations, resulting in different fusion gene products, such as TMPSSR2-ERG and NDRG1-ERG in prostate cancer, EWS-ERG in Ewing's sarcoma and FUS-ERG in acute myeloid leukemia. More than two dozens of transcript variants generated from combinatorial usage of three alternative promoters and multiple alternative splicing events have been reported, but the full-length nature of many of these variants has not been determined. [provided by RefSeq, Apr 2014]
ERG Gene-Disease associations (from GenCC):
  • lymphatic malformation 14
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.476 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_182918.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ERG
NM_182918.4
MANE Select
c.745+2132A>G
intron
N/ANP_891548.1P11308-4
ERG
NM_001136154.1
c.766+2132A>G
intron
N/ANP_001129626.1P11308-3
ERG
NM_001243428.1
c.766+2132A>G
intron
N/ANP_001230357.1P11308-3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ERG
ENST00000288319.12
TSL:1 MANE Select
c.745+2132A>G
intron
N/AENSP00000288319.7P11308-4
ERG
ENST00000398919.6
TSL:1
c.766+2132A>G
intron
N/AENSP00000381891.2P11308-3
ERG
ENST00000398905.5
TSL:1
c.673+4115A>G
intron
N/AENSP00000381877.1B5MDW0

Frequencies

GnomAD3 genomes
AF:
0.387
AC:
58840
AN:
151966
Hom.:
12745
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.195
Gnomad AMI
AF:
0.427
Gnomad AMR
AF:
0.318
Gnomad ASJ
AF:
0.428
Gnomad EAS
AF:
0.401
Gnomad SAS
AF:
0.399
Gnomad FIN
AF:
0.610
Gnomad MID
AF:
0.468
Gnomad NFE
AF:
0.480
Gnomad OTH
AF:
0.385
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.387
AC:
58832
AN:
152084
Hom.:
12741
Cov.:
32
AF XY:
0.393
AC XY:
29219
AN XY:
74338
show subpopulations
African (AFR)
AF:
0.195
AC:
8075
AN:
41502
American (AMR)
AF:
0.318
AC:
4854
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.428
AC:
1486
AN:
3470
East Asian (EAS)
AF:
0.401
AC:
2070
AN:
5160
South Asian (SAS)
AF:
0.401
AC:
1930
AN:
4814
European-Finnish (FIN)
AF:
0.610
AC:
6441
AN:
10566
Middle Eastern (MID)
AF:
0.466
AC:
137
AN:
294
European-Non Finnish (NFE)
AF:
0.480
AC:
32645
AN:
67986
Other (OTH)
AF:
0.381
AC:
805
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1729
3457
5186
6914
8643
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
566
1132
1698
2264
2830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.415
Hom.:
23923
Bravo
AF:
0.358
Asia WGS
AF:
0.365
AC:
1266
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
3.9
DANN
Benign
0.65
PhyloP100
-0.17
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2836370; hg19: chr21-39770364; API